4 published verifications about Acupuncture Acupuncture ×
“In acupuncture assessment for migraine, practitioners evaluate a patient's body balance using methods such as pulse reading, tongue observation, and physical examination to identify patterns of imbalance.”
The claim accurately describes standard TCM-style acupuncture assessment for migraine. Major medical and NIH-linked sources describe acupuncturists using pulse reading, tongue observation, and physical examination to identify patterns of imbalance before treatment. The main caveat is that these steps are part of traditional diagnostic practice and are not always standardized or detailed in migraine guidelines or clinical trials.
“After an initial course of acupuncture for migraine management, maintenance acupuncture sessions are typically done monthly or as needed.”
The evidence does not support monthly or as-needed acupuncture as the typical maintenance schedule for migraine after an initial course. Authoritative reviews and guidelines generally describe individualized treatment plans or fixed short-term courses, and they do not establish a standard maintenance cadence. Some clinics recommend monthly follow-up, but that reflects local practice patterns rather than broad evidence-based consensus.
“Acupuncture sessions for migraine treatment typically last 45–60 minutes, including consultation time.”
Full acupuncture visits for migraine can last 45–60 minutes when consultation is counted, but that is not the best-supported typical range. Authoritative migraine and general medical sources more often place routine sessions around 30–45 minutes, with 60 minutes commonly describing initial or longer appointments. The claim therefore overstates how long a standard session usually lasts.
“Acupuncture is used both for migraine prevention (reducing future migraine attack frequency) and for relief during an active migraine attack.”
Available evidence supports both parts of the claim. Acupuncture is well studied as a preventive option for migraine, with multiple systematic reviews showing reduced attack frequency. It has also been used during active migraine attacks in trials and some clinical settings, although the acute-use evidence is much smaller and it is not a standard first-line abortive treatment.